Summary:
Thrombotic microangiopathy after bone marrow transplantation (post-BMT TMA) is a serious transplant-related complication. We identified 16 patients with TMA after allogeneic BMT who showed histopathological evidence of intestinal TMA in their gut specimens (six autopsies, 10 biopsies). In all, 14 patients had grade II–IV acute graft-versus-host disease (GVHD). The first seven patients were retrospectively diagnosed with TMA. Since six of them were diagnosed with progressive GVHD at that time because there was no awareness of the existence of intestinal TMA, they received more intensive treatment for GVHD, but all died between days +49 and +253. In contrast, the remaining nine patients were recently diagnosed with intestinal TMA on the basis of colonoscopic biopsies. For eight of these patients, the immunosuppressants were reduced, and the patients’ intestinal symptoms improved gradually. Six of the nine patients were still alive 12 months after the diagnosis of TMA. Our findings suggest that the gut may be a site involved in post-BMT TMA, presenting as ischemic enterocolitis. Differentiating intestinal TMA from acute GVHD is important in patients suffering from severe and refractory diarrhea after BMT.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Pettitt AR, Clark RE . Thrombotic microangiopathy following bone marrow transplantation. Bone Marrow Transplant 1994; 14: 495–504.
Zeigler ZR, Shadduck RK, Nemunaitis J et al. Bone marrow transplant-associated thrombotic microangiopathy: a case series. Bone Marrow Transplant. 1995; 15: 247–253.
Zeigler ZR, Shadduck RK, Nath R, Andrews III DF . Pilot study of combined cryosupernatant and protein A immunoadsorption exchange in the treatment of grade 3–4 bone marrow transplant-associated thrombotic microangiopathy. Bone Marrow Transplant 1996; 17: 81–86.
Daly AS, Xenocostas A, Lipton JH . Transplantation-associated thrombotic microangiopathy: twenty-two years later. Bone Marrow Transplant 2002; 30: 709–715.
Moake JL, Byrnes JJ . Thrombotic microangiopathies associated with drugs and bone marrow transplantation. Hematol Oncol Clin N Am 1996; 10: 485–497.
Holler E, Kolb HJ, Hiller E et al. Microangiopathy in patients on cyclosporine prophylaxis who developed acute graft-versus-host disease after HLA-identical bone marrow transplantation. Blood 1989; 73: 2018–2024.
Chappel ME, Keeling DM, Prentice HG, Sweny P . Haemolytic uraemic syndrome after bone marrow transplantation: an adverse effect of total body irradiation? Bone Marrow Transplant 1988; 3: 339–347.
Juckett M, Perry EH, Daniels BS, Weisdorf DJ . Hemolytic uremic syndrome following bone marrow transplantation. Bone Marrow Transplant 1991; 7: 405–409.
Rabinowe SN, Soiffer RJ, Tarbell NJ et al. Hemolytic–uremic syndrome following bone marrow transplantation in adults for hematologic malignancies. Blood 1991; 77: 1837–1844.
Hill GR, Crawford JM, Cooke KR et al. Total body irradiation and acute graft-versus-host disease: The role of gastrointestinal damage and inflammatory cytokines. Blood 1997; 90: 3204–3213.
Tezcan H, Zimmer W, Fenstermarker R et al. Severe cerebellar swelling and thrombotic thrombocytopenic purpura associated with FK506. Bone Marrow Transplant 1998; 21: 105–109.
Kondo M, Kojima S, Horibe K et al. Hemolytic uremic syndrome after allogeneic or autologous hematopoietic stem cell transplantation for childhood malignancies. Bone Marrow Transplant 1998; 21: 281–286.
Paquette RL, Tran L, Landaw EM . Thrombotic microangiopathy following allogeneic bone marrow transplantation is associated with intensive graft-versus-host disease prophylaxis. Bone Marrow Transplant 1998; 22: 351–357.
Trimarchi HM, Truong LD, Breunan S et al. FK506-associated thrombotic microangiopathy: report of two cases and review of literature. Transplantation 1999; 67: 539–544.
Uderzo C, Fumagalli M, Lorenzo PD et al. Impact of thrombotic thrombocytopenic purpura on leukemic children undergoing bone marrow transplantation. Bone Marrow Transplant 2000; 26: 1005–1009.
Roy V, Rizvi MA, Vesely SK, George JN . Thrombotic thrombocytopenic purpura-like syndromes following bone marrow transplantation: an analysis of associated conditions and clinical outcomes. Bone Marrow Transplant 2001; 27: 641–646.
Griffin PM, Olmstead LC, Petras RE . Eschericia coli O157:H7-associated colitis. Gastroenterology 1990; 99: 142–149.
Boyce TG, Swerdlow DL, Griffin PM . Eschericia coli O157:H7 and the hemolytic–uremic syndrome. N Engl J Med 1995; 333: 364–368.
Kwaan HC . Clinicopathologic features of thrombotic thrombocytopenic purpura. Semin Hematol 1987; 24: 71–81.
Zomas A, Saso R, Powles R et al. Red cell fragmentation (schistocytosis) after bone marrow transplantation. Bone Marrow Transplant 1998; 22: 777–780.
Przepiorka D, Weisdorf D, Martin P et al. 1994 Consensus Conference on acute GVHD grading. Bone Marrow Transplant 1995; 15: 825–828.
Shulman HM, Sullivan KM, Weiden PL et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980; 69: 204–217.
McDonald GB, Shulman HM, Sullivan KM, Spencer GD . Intestinal and hepatic complications of human bone marrow transplantation. Part I. Gastroenterology 1986; 90: 460–477.
Einsele H, Ehninger G, Hebart H et al. Incidence of local CMV infection and acute intestinal GVHD in marrow transplant recipients with severe diarrhoea. Bone Marrow Transplant 1994; 14: 955–963.
Cox GJ, Matsui SM, Lo RS et al. Etiology and outcome of diarrhea after marrow transplantation: a prospective study. Gastroenterology 1994; 107: 1398–1407.
Epstein RJ, McDonald GB, Sale GE et al. The diagnostic accuracy of the rectal biopsy in acute graft-versus-host disease: a prospective study of thirteen patients. Gastroenterology 1980; 78: 764–771.
Thorning D, Howard JD . Epithelial denudement in the gastrointestinal tracts of two bone marrow transplant recipients. Hum Pathol 1986; 17: 560–566.
Sale GE, McDonald GB, Shulman HM, Thomas ED . Gastrointestinal graft-versus-host disease in man: a clinicopathologic study of the rectal biopsy. Am J Surg Pathol 1979; 3: 291–299.
Fox RJ, Vogelsang GB, Beschorner WE . Denuded bowel after recovery from graft-versus-host disease. Transplantation 1996; 62: 1681–1684.
Bombi JA, Nadal A, Carreras E et al. Assessment of histopathologic changes in the colonic biopsy in acute graft-versus-host disease. Am J Clin Pathol 1995; 103: 690–695.
Voss BL, Hamilton KK, Samama ENS, McKee PA . Cyclosporine suppression of endothelial prostacyclin generation. Transplantation 1988; 45: 793–796.
Yoshida M, Kozaki M, Ioya N et al. Plasma thrombomodulin levels as an indicator of vascular injury caused by cyclosporine nephrotoxicity. Transplantation 1990; 50: 1066–1069.
Garcia-Maldonado M, Kaufman CE, Comp PC . Decrease in endothelial cell-dependent protein C activation induced thrombomodulin by treatment with cyclosporine. Transplantation 1991; 51: 701–705.
Cohen H, Neild GH, Patel R et al. Evidence for chronic platelet hyperaggregability and in vivo activation in cyclosporin-treated renal allograft recipients. Thromb Res 1988; 49: 91–101.
Blajchman MA, Senyi AF, Hirsh J et al. Shortening of the bleeding time in rabbits by hydrocortisone caused by inhibition of prostacyclin generation by the vessel wall. J Clin Invest 1979; 63: 1026–1035.
Lewis GD, Campbell WB, Johnson AR . Inhibition of prostaglandin synthesis by glucocorticoids in human endothelial cells. Endocrinology 1986; 119: 62–69.
Mihatsch MJ, Kyo M, Morozumi K et al. The side-effects of cyclosporine-A and tacrolimus. Clin Nephrol 1998; 49: 356–363.
Gaziev D, Galimberti M, Lucarelli G, Polchi P . Chronic graft-versus-host disease: is there an alternative to the conventional treatment? Bone Marrow Transplant 2000; 25: 689–696.
Acknowledgements
We thank Dr Takeo Yamaguchi, Dr Junichi Haruta and Dr Masafumi Ito for their helpful comments. This study was supported by Grants-in-Aid for Cancer Research (7-3) from the Ministry of Health and Welfare, Japan.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nishida, T., Hamaguchi, M., Hirabayashi, N. et al. Intestinal thrombotic microangiopathy after allogeneic bone marrow transplantation: a clinical imitator of acute enteric graft-versus-host disease. Bone Marrow Transplant 33, 1143–1150 (2004). https://doi.org/10.1038/sj.bmt.1704512
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1704512
Keywords
This article is cited by
-
Endoscopic manifestation of intestinal transplant-associated microangiopathy after stem cell transplantation
BMC Gastroenterology (2024)
-
Diffuse alveolar hemorrhage: An underreported complication of transplant associated thrombotic microangiopathy
Bone Marrow Transplantation (2022)
-
Utility of novel T-cell-specific extracellular vesicles in monitoring and evaluation of acute GVHD
International Journal of Hematology (2021)
-
Intestinal thrombotic microangiopathy: a distinct entity in the spectrum of graft-versus-host disease
International Journal of Hematology (2019)
-
Prediction of clinical outcome by controlling nutritional status (CONUT) before allogeneic hematopoietic stem cell transplantation in myeloid malignancies
International Journal of Hematology (2019)